XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Common Stock and Stock-Based Compensation
6 Months Ended
Sep. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Common Stock and Stock-Based Compensation

12. Common Stock and Stock-Based Compensation

Restricted Stock Units

The following table summarizes the Company’s RSU activity for the six months ended September 29, 2023:

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Outstanding at March 31, 2023

 

 

2,251,224

 

 

$

23.85

 

Granted

 

 

907,364

 

 

 

38.32

 

Issued

 

 

(782,561

)

 

 

24.11

 

Forfeited

 

 

(60,452

)

 

 

25.65

 

Outstanding at September 29, 2023

 

 

2,315,575

 

 

$

29.41

 

 

As of September 29, 2023, total unrecognized compensation expense for awards issued was $55,834, which is expected to be recognized over a weighted-average period of 2.41 years. The total grant date fair value of RSUs vested was $18.8 million for the six months ended September 29, 2023.

Performance Stock Units

The following table summarizes the Company’s PSU activity for the six months ended September 29, 2023:

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Outstanding at March 31, 2023

 

 

2,748,347

 

 

$

23.47

 

Granted

 

 

298,783

 

 

 

40.56

 

Excess shares issued due to achievement of performance condition

 

 

462,739

 

 

 

24.99

 

Issued

 

 

(215,883

)

 

 

24.79

 

Forfeited

 

 

(47,414

)

 

 

23.28

 

Outstanding at September 29, 2023

 

 

3,246,572

 

 

$

24.32

 

 

Included in the outstanding shares are 396,171 and 486,229 shares as of March 31, 2023 and September 29, 2023, respectively, that have vested but have not been issued. PSUs are included at 0% - 200% of target goals. The total compensation cost related to unvested awards not yet recorded at September 29, 2023 was $22,267, which is expected to be recognized over a weighted average period of 2.28 years. The total grant date fair value of PSUs vested was $5.4 million for the six months ended September 29, 2023.

The Company recorded stock-based compensation expense in the following expense categories of its unaudited condensed consolidated statements of operations:

 

 

Three-Month Period Ended

 

 

Six-Month Period Ended

 

 

September 29,
2023

 

 

September 23,
2022

 

 

September 29,
2023

 

 

September 23,
2022

 

Cost of sales

 

$

946

 

 

$

1,124

 

 

$

3,552

 

 

$

1,956

 

Research and development

 

 

3,602

 

 

 

1,711

 

 

 

6,470

 

 

 

2,839

 

Selling, general and administrative

 

 

6,329

 

 

 

5,369

 

 

 

11,897

 

 

 

37,545

 

Total stock-based compensation

 

$

10,877

 

 

$

8,204

 

 

$

21,919

 

 

$

42,340